We are live on ! Find out more
TI

Telemetry Investments Portfolio holdings

AUM $63.3M
1-Year Est. Return 0.06%
This Fund
S&P 500
This Quarter Est. Return
+25.65%
1 Year Est. Return
+0.06%
3 Year Est. Return
+77.42%
5 Year Est. Return
+156.79%
10 Year Est. Return
AUM
$59.2M
AUM Growth
+$13.2M
Cap. Flow
+$4.59M
Cap. Flow %
7.75%
Top 10 Hldgs %
28.63%
Holding
110
New
37
Increased
14
Reduced
17
Closed
21

Sector Composition

Rank Sector Weight
1 Healthcare 18.02%
2 Financials 9.95%
3 Technology 6.76%
4 Communication Services 4.3%
5 Energy 2.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VSTM icon
76
Verastem
VSTM
$519M
$224K 0.38%
8,750
-4,583
-34% -$92.1K
NAV
77
DELISTED
Navistar International
NAV
$224K 0.38%
+5,100
New +$222K
DHR icon
78
Danaher
DHR
$141B
$223K 0.38%
+1,133
New +$227K
FE icon
79
FirstEnergy
FE
$27.4B
$223K 0.38%
7,300
-300
-4% -$8.99K
UROV
80
DELISTED
Urovant Sciences Ltd.
UROV
$204K 0.34%
+12,633
New +$157K
MSFT icon
81
Microsoft
MSFT
$3.71T
$200K 0.34%
+900
New +$194K
EIGI
82
DELISTED
Endurance International Group Holdings, Inc.
EIGI
$198K 0.33%
+21,000
New +$174K
DOYU
83
DouYu International Holdings
DOYU
$137M
$187K 0.32%
+1,690
New +$229K
SU icon
84
Suncor Energy
SU
$72.4B
$168K 0.28%
+10,000
New +$147K
VCNX
85
DELISTED
Vaccinex, Inc. Common Stock
VCNX
$157K 0.27%
362
+84
+30% +$35.1K
FRTX
86
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$153K 0.26%
+4,353
New +$137K
CBB
87
DELISTED
Cincinnati Bell Inc.
CBB
$153K 0.26%
+10,000
New +$152K
TCON
88
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$120K 0.2%
511
-2,225
-81% -$310K
BMY.RT
89
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$7K 0.01%
+10,000
New +$21.3K
AEM icon
90
Agnico Eagle Mines
AEM
$85B
-2,700
Closed -$215K
BMY icon
91
Bristol-Myers Squibb
BMY
$131B
-3,800
Closed -$229K
FBIO icon
92
Fortress Biotech
FBIO
$92M
-1,225
Closed -$74K
GILT icon
93
Gilat Satellite Networks
GILT
$852M
-13,463
Closed -$73K
REGN icon
94
Regeneron Pharmaceuticals
REGN
$79.5B
-2,500
Closed -$1.4M
XTNT icon
95
Xtant Medical Holdings
XTNT
$62.1M
-146,139
Closed -$120K
HUD
96
DELISTED
Hudson Ltd. Class A Common Shares
HUD
-10,000
Closed -$76K
WMGI
97
DELISTED
Wright Medical Group Inc
WMGI
-11,455
Closed -$350K
ADSW
98
DELISTED
Advanced Disposal Services Inc
ADSW
-9,010
Closed -$272K
LVGO
99
DELISTED
Livongo Health, Inc. Common Stock
LVGO
-7,400
Closed -$1.04M
IMMU
100
DELISTED
Immunomedics Inc
IMMU
-7,191
Closed -$611K

Similar funds

Telemetry Investments's Q4 2020 Portfolio in Review

As of Q4 2020, Telemetry Investments held 110 positions worth $59.2M, up 29% from $46M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Telemetry Investments deployed $4.59M of net new capital in Q4 2020, opening 37 new positions and adding to 14 existing holdings. Its largest new stake was Xilinx Inc: 11,600 shares worth $1.65M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 28% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was HUMANIGEN, INC., an estimated $1.13M trimmed.

  • Telemetry Investments's largest Q4 2020 buy was Xilinx Inc: 11,600 shares worth $1.65M.
  • Telemetry Investments added most to Tiffany & Co. in Q4 2020, an estimated $870K increase.
  • Telemetry Investments's biggest Q4 2020 reduction was HUMANIGEN, INC., cutting an estimated $1.13M.
  • Telemetry Investments fully exited E*Trade Financial Corporation in Q4 2020, selling an estimated $1.78M.
  • Telemetry Investments's ten largest holdings make up 29% of its $59.2M portfolio in Q4 2020.
  • Telemetry Investments opened 37 new positions and closed 21 in Q4 2020.
  • Telemetry Investments's portfolio value rose 29% quarter-over-quarter to $59.2M.

Based on Telemetry Investments's 13F filing for Q4 2020, filed 16 Feb 2021.